72 related articles for article (PubMed ID: 22331511)
1. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.
Bilici A; Ustaalioglu BB; Yavuzer D; Seker M; Mayadagli A; Gumus M
Dig Dis Sci; 2012 Jun; 57(6):1568-75. PubMed ID: 22331511
[TBL] [Abstract][Full Text] [Related]
2. A retrospective cohort study of clinical value of PRL-3 in stage III human colorectal cancer.
Liu C; Zhong W; Xia L; Fang C; Liu H; Liu X
Medicine (Baltimore); 2021 Apr; 100(17):e25658. PubMed ID: 33907129
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal and Phosphatase of Regenerating Liver-3 Status in Circulating Tumor Cells May Serve as a Crucial Prognostic Marker for Assessing Relapse or Metastasis in Postoperative Patients With Colorectal Cancer.
Su P; Lai W; Liu L; Zeng Y; Xu H; Lan Q; Chu Z; Chu Z
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00265. PubMed ID: 33512811
[TBL] [Abstract][Full Text] [Related]
4. Subclassification of stage IV gastric cancer (IVa, IVb, and IVc) and prognostic significance of substages.
Ma Y; Xue Y; Li Y; Lan X; Zhang Y; Zhang M
J Gastrointest Surg; 2010 Mar; 14(3):484-92. PubMed ID: 19949998
[TBL] [Abstract][Full Text] [Related]
5. Extra-perigastric Extranodal Metastasis is a Significant Prognostic Factor in Node-Positive Gastric Cancer.
Tonouchi A; Sugano M; Tokunaga M; Sugita S; Watanabe M; Sato R; Kaito A; Akimoto T; Ochiai A; Kinoshita T; Kuwata T
World J Surg; 2019 Oct; 43(10):2499-2505. PubMed ID: 31312947
[TBL] [Abstract][Full Text] [Related]
6. The ratio of intratumoral CD15
Watanabe J; Kimura T; Saze Z; Sato N; Kofunato Y; Ishigame T; Okada R; Kenjo A; Kono K; Marubashi S
Cancer Rep (Hoboken); 2024 Jun; 7(6):e2099. PubMed ID: 38837676
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism of IGF-I predicts recurrence in patients with gastric cancer who have undergone curative gastrectomy.
Shitara K; Ito S; Misawa K; Ito Y; Ito H; Hosono S; Watanabe M; Tajima K; Tanaka H; Muro K; Matsuo K
Ann Oncol; 2012 Mar; 23(3):659-664. PubMed ID: 21690232
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Tumor Budding in Predicting Survival for Gastric Carcinoma Patients in Vietnam.
Dao TV; Nguyen CV; Nguyen QT; Vu HTN; Phung HT; Bui OT; Nguyen DK; Luong BV; Tran TV
Cancer Control; 2020; 27(1):1073274820968883. PubMed ID: 33136444
[TBL] [Abstract][Full Text] [Related]
9. Increased CD44 Expression and MEK Activity Predict Worse Prognosis in Gastric Adenocarcinoma Patients Undergoing Gastrectomy.
Lin JX; Yoon C; Li P; Yu Q; Qiu SL; Zheng CH; Yoon SS; Huang CM
J Gastrointest Surg; 2021 May; 25(5):1147-1155. PubMed ID: 32410176
[TBL] [Abstract][Full Text] [Related]
10. Exceeding 30 ELNs is strongly recommended for pT3-4N0 patients with gastric cancer: A multicenter study of survival, recurrence, and prediction model.
Zhao L; Han W; Yang X; Zhao D; Niu P; Gao X; Wu Z; Zhang X; Li Z; Ji G; Chen Y
Cancer Sci; 2021 Aug; 112(8):3266-3277. PubMed ID: 34080256
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer.
Kong F; Gao F; Chen J; Zheng R; Liu H; Li X; Yang P; Liu G; Jia Y
Oncotarget; 2016 Aug; 7(34):55765-55770. PubMed ID: 27303917
[TBL] [Abstract][Full Text] [Related]
12. Asialoglycoprotein Receptor 2 Expression in Patients With Locally Advanced Gastric Cancer After Curative Resection.
Oshima T; Hashimoto I; Hiroshima Y; Kimura Y; Tanabe M; Onuma S; Nagasawa S; Kanematsu K; Aoyama T; Yamada T; Ogata T; Rino Y; Saito A; Miyagi Y
Anticancer Res; 2024 Jan; 44(1):397-402. PubMed ID: 38159992
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of frailty after gastrectomy in elderly gastric cancer patients.
Nishi M; Wada Y; Yoshikawa K; Takasu C; Tokunaga T; Nakao T; Kashihara H; Yamada S; Yoshimoto T; Shimada M
J Med Invest; 2023; 70(3.4):423-429. PubMed ID: 37940527
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Pregnancy Zone Protein Expression in Patients With Locally Advanced Gastric Cancer After Curative Resection.
Oshima T; Hashimoto I; Hiroshima Y; Kimura Y; Tanabe M; Onuma S; Morita J; Nagasawa S; Kanematsu K; Aoyama T; Yamada T; Ogata T; Rino Y; Saito A; Miyagi Y
Anticancer Res; 2024 Jan; 44(1):369-374. PubMed ID: 38159976
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of CD208-positive cell infiltration in gastric cancer.
Ishigami S; Ueno S; Matsumoto M; Okumura H; Arigami T; Uchikado Y; Setoyama T; Arima H; Sasaki K; Kitazono M; Shinchi H; Kijima Y; Natsugoe S
Cancer Immunol Immunother; 2010 Mar; 59(3):389-95. PubMed ID: 19760221
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Significance and Prognostic Role of Her2neu Protein Expression in Patients with Carcinoma Stomach: A Prospective Study from Northern India.
B AV; Behera MK; Patne SCU; Shukla SK; Dixit VK
South Asian J Cancer; 2023 Apr; 12(2):135-140. PubMed ID: 37969677
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy induced PRL3 expression promotes cancer growth via plasma membrane remodeling and specific alterations of caveolae-associated signaling.
Csoboz B; Gombos I; Tatrai E; Tovari J; Kiss AL; Horvath I; Vigh L
Cell Commun Signal; 2018 Aug; 16(1):51. PubMed ID: 30157875
[TBL] [Abstract][Full Text] [Related]
18. Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD-negative acute myeloid leukemia.
Qu S; Liu B; Guo X; Shi H; Zhou M; Li L; Yang S; Tong X; Wang H
Cancer; 2014 Jul; 120(14):2130-41. PubMed ID: 24737397
[TBL] [Abstract][Full Text] [Related]
19. PRL-3 and E-cadherin show mutual interactions and participate in lymph node metastasis formation in gastric cancer.
Pryczynicz A; Guzińska-Ustymowicz K; Niewiarowska K; Cepowicz D; Kemona A
Tumour Biol; 2014 Jul; 35(7):6587-92. PubMed ID: 24696260
[TBL] [Abstract][Full Text] [Related]
20. Phosphatase of regenerating liver: a novel target for cancer therapy.
Campbell AM; Zhang ZY
Expert Opin Ther Targets; 2014 May; 18(5):555-69. PubMed ID: 24579927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
